FDA Approves mRNA-Based Flu Vaccine

The Moderna vaccine has been authorized for adults aged 50-64. The Food and Drug Administration approved the Moderna mRNA-based flu vaccine this week, according to the pharmaceutical company.…

Read More

FDA Approves New COVID-19 Vaccines with Restrictions

The emergency use authorization has been rescinded as the approval is for seniors and those who are high risk. The Food and Drug Administration set new limits for…

Read More

HHS Reevaluates Human Bird Flu Vaccine Contract with Moderna

The agency is considering rescinding the $590 million contract awarded by President Biden’s administration. The Department of Health and Human Services (HHS) confirmed that it is reevaluating a…

Read More

HHS Allocated Funding to Moderna for mRNA Vaccines Prior to Presidential Inauguration

The department stated the $590 million in funding will strengthen U.S. preparedness through technology. The Department of Health and Human Services (HHS) awarded Moderna approximately $590 million days…

Read More

FDA Authorizes Pfizer’s and Moderna’s Updated COVID-19 Vaccines

Officials say the update is formulated to address the most recent subvariant. The Food and Drug Administration (FDA) has authorized Pfizer and Moderna’s updated COVID-19 vaccines, to address…

Read More

Senator Sanders Addresses Moderna Vaccine Prices

The company is planning an increase in the commercial cost per dose. Senator Bernie Sanders of Vermont sent a letter to medicine manufacturer Moderna, urging them not to…

Read More

FDA Authorizes Bivalent COVID-19 Boosters

Boosters could roll out as soon as next week if approved The Food and Drug Administration has issued emergency authorizations for the bivalent vaccines produced by Moderna and…

Read More

“Bivalent” Vaccines Submitted for FDA Approval

Moderna and Pfizer incorporate subvariants into original formula. The Food and Drug Administration has received requests for authorization of newly-developed COVID-19 vaccines from Moderna and Pfizer. The “bivalent”…

Read More

U.S. Receives 3.2 Million Novavax COVID-19 Vaccines

 Protein-based vaccine is waiting for FDA approval and CDC recommendation. This week, the Department of Health and Human Services (HHS) announced they have received 3.2 million doses of…

Read More

CDC Reports Omicron 52% of Current COVID-19 Cases

Vaccine producers testing formulas against sub-variants. The Centers for Disease Control and Prevention (CDC) released a report this week showing that the BA.4 and BA.5 sub-variants of Omicron…

Read More
Back to top
FE3